目录号 | 产品名称 | 中文名称 | 靶点 |
---|---|---|---|
M40918 | Anti-Mouse Ly6G (Clone 1A8) In vivo | Anti-Mouse Ly6G (Clone 1A8) In vivo | Immunology/Inflammation |
Anti-Mouse Ly6G antibody (Clone 1A8) In vivo recognizes an epitope on mouse Ly6G. Ly6G is expressed by neutrophils. | |||
M40909 | Anti-Mouse CD8a (Clone 53-6.7) In vivo | Anti-Mouse CD8a (Clone 53-6.7) In vivo | Immunology/Inflammation |
Lyt2, Ly-2 | |||
Anti-Mouse CD8a (Clone 53-6.7) In vivo recognizes Lyt 2. Clone 53-6.7 competes with clone 5H10-1 for binding to thymocytes. | |||
M40856 | Anti-Mouse CD4 (Clone YTS191) In vivo | Anti-Mouse CD4 (Clone YTS191) In vivo | GPR/FFAR |
Anti-Mouse CD4 (Clone YTS191) In vivo 可与小鼠CD4结合反应。CD4是T细胞受体(TCR)的协同受体,有助于后续与抗原呈递细胞的交流通讯。 | |||
M40830 | Anti-Mouse CD3ε In vivo | Anti-Mouse CD3ε In vivo | Immunology/Inflammation |
Anti-Mouse CD3Epsilon | |||
Anti-Mouse CD3ε (Clone 145-2C11) In vivo单克隆抗体与小鼠CD3ε反应。小鼠CD3ε是一种20 kDa的跨膜细胞表面蛋白,属于免疫球蛋白超家族。 | |||
M40828 | Anti-Mouse CTLA-4 (Clone 9H10) In vivo | Anti-Mouse CTLA-4 (Clone 9H10) In vivo | Immunology/Inflammation |
Cytotoxic T Lymphocyte-Associated Antigen-4 | |||
Anti-Mouse CTLA-4 (Clone 9H10) recognizes an epitope on mouse CTLA-4. CTLA-4 is expressed on activated T and B lymphocytes. | |||
M40812 | Anti-Mouse Ly-6G/Ly-6C (Clone RB6-8C5) In vivo | Anti-Mouse Ly-6G/Ly-6C (Clone RB6-8C5) In vivo | Immunology/Inflammation |
Anti-Mouse GR-1 | |||
Anti-Mouse Ly-6G/Ly-6C (Clone RB6-8C5) In vivo has been used to identify peripheral blood neutrophils and deplete granulocytes in vivo. | |||
M40806 | Anti-Mouse NK1.1 In vivo | Anti-Mouse NK1.1 In vivo | Others |
This NK1.1 antibody (clone PK136) recognizes mouse NK1.1. NK1.1 is a type II membrane protein that is part of the C-type lectin superfamily. | |||
M40797 | Anti-Mouse IFNγ (interferon gamma) (Clone XMG1.2) In vivo | Anti-Mouse IFNγ (interferon gamma) (Clone XMG1.2) In vivo | Interferon-α/β/γ |
IFNG | |||
Anti-Mouse IFNγ 单克隆抗体与小鼠 IFNγ (interferon gamma) 反应。IFNγ是一种20 kDa的可溶性多效性细胞因子,是II型干扰素的唯一成员。 | |||
M40795 | Anti-Mouse IL-4 In vivo | Anti-Mouse IL-4 In vivo | IL Receptor/Related |
Interleukin-4 | |||
Anti-Mouse IL-4 In vivo单克隆抗体可与小鼠IL-4 (interleukin-4)反应。Anti-Mouse IL-4 In vivo单克隆抗体可中和天然或重组IL-4的生物活性。 | |||
M40769 | Anti-Mouse/Human TGF-β In vivo | Anti-Mouse/Human TGF-β In vivo | TGF-beta/Smad |
Anti-Mouse/Human TGF-β1, 2, 3 | |||
Anti-Mouse/Human TGF-β In vivo (Clone: 1D11.16.8) 单克隆抗体与小鼠,人类,大鼠,猴子,仓鼠,犬和牛的TGF-β1、2 和 3反应。该抗体是中和抗体。 | |||
M40768 | Anti-Mouse IFNAR-1 In vivo | Anti-Mouse IFNAR-1 In vivo | Interferon-α/β/γ |
Anti-Mouse IFNAR-1 In vivo 单克隆抗体(Clone: MAR1-5A3)可与 mouse IFNAR-1 (IFN alpha/beta receptor subunit 1) 发生反应。Anti-Mouse IFNAR-1 In vivo 可在体外和体内抑制 I 型 IFN 受体信号传导。 | |||
M40764 | Anti-Mouse PD-L1 In vivo | Anti-Mouse PD-L1 In vivo | PD-1/PD-L1 |
B7-H1, CD274 | |||
Anti-Mouse PD-L1 Antibody (Clone 10F.9G2) 单克隆抗体可与小鼠 PD-L1(也称为B7-H1、CD274)发生反应。10F.9G2 抗体已被证明可以阻断 PD-L1 和 PD-1 之间以及 PD-L1 和 B7-1 (CD80) 之间的相互作用。 | |||
M40599 | Ocrelizumab | 奥瑞珠单抗;奥瑞利珠单抗 | CD20 |
Ocrelizumab是一种人源化抗CD20单克隆抗体,可用于多发性硬化的相关研究。 | |||
M25280 | Romosozumab | Romosozumab | Others |
Romosozumab是首款靶向Sclerostin的人源化IgG2单抗。Romosozumab 是一种人源化抗硬化蛋白单克隆抗体,可通过抑制骨吸收促进骨形成和抑制骨硬化素。Romosozumab 可用于骨质疏松的研究。 | |||
M25263 | Tanezumab | Tanezumab | Others |
RN-624; PF 4383119 | |||
Tanezumab (RN-624) 是一种具有高亲和力和特异性的人源化抗 NGF 单克隆抗体,能阻断 NGF 与周围神经系统中的受体 p75 和 TrkA 结合。Tanezumab 可用于急性和慢性疼痛,如骨关节炎,膝关节和神经痛和带状疱疹后神经痛的研究。 | |||
M25253 | Tremelimumab | 曲美木单抗 | Others |
Ticilimumab; CP-675206 | |||
Tremelimumab (Ticilimumab) 是一种完全人源化的单克隆抗体,对细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 具有特异性,可用于转移性黑色素瘤研究。 | |||
M25003 | Talquetamab | Talquetamab | Others |
JNJ-64407564 | |||
Talquetamab(JNJ-64407564)是一种潜在首创的(first-in-class)人源化IgG4ҡ/λ双特异性抗体,可与 GPRC5D (G 蛋白偶联受体家族C5组成员 D) 和 CD3 结合,通过T 细胞的募集和活化诱导 T 细胞介导的杀死表达 GPRC5 的 MM 细胞。Talquetamab(JNJ-64407564)具有抗肿瘤活性。 | |||
M24911 | Pozelimab | 帕泽利单抗 | Complement System |
REGN3918 | |||
Pozelimab (REGN3918) 是一种人 IgG4 抗补体 C5 单克隆抗体。Pozelimab 高亲和力的结合 C5 和 C5 变体,阻断补体介导的溶血。Pozelimab 可用于补体介导疾病的研究。 | |||
M24855 | Donanemab | 多奈单抗,多纳单抗 | Amyloid |
LY3002813 | |||
Donanemab (LY3002813) 是一种针对 N 末端焦谷氨酸β淀粉样蛋白 (Aβ) 表位的人源化 IgG1κ 单克隆抗体。能通过与淀粉样蛋白N3pG亚型特异性结合,从而促进淀粉样斑块的清除。可用于阿尔茨海默病(AD)的相关研究。 | |||
M24841 | Palivizumab | 帕利珠单抗 | RSV |
MEDI 493 | |||
Palivizumab (MEDI 493) 是一种人源化呼吸道合胞病毒单克隆抗体,可减少呼吸道合胞病毒感染 (RSV)。 |
产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。
Copyright © 2010-2022 AbMole版权所有 沪ICP备16047849号 沪公网安备 31011502012228号